Table 4.
Association of HIV clinical and treatment factors with positive remodeling
| n1 | Individual Model Odds Ratio |
95% CI | Combined Model Odds Ratio (n=436) |
95% CI | |
|---|---|---|---|---|---|
| Detectable HIV RNA (> 50 copies/mL) | 450 | 0.69 | 0.27, 1.78 | ||
| History of AIDS | 453 | 2.40* | 1.04, 5.57 | 2.04 | 0.84, 4.93 |
| Duration on HAART (years) | 448 | 1.03 | 0.96, 1.12 | ||
| Protease Inhibitor Use (years) | 448 | 1.04 | 0.98, 1.11 | ||
| Current CD4+ T cell count (per 100 cells) | 449 | 1.06 | 0.94, 1.19 | ||
| Nadir CD4+ T cell count (per 100 cells) | 436 | 0.81* | 0.67, 0.98 | 0.82* | 0.67, 0.99 |
OR=Odds Ratio. CI=Confidence Internal.
*
p < 0.05,
**
p < 0.01,
***
p < 0.001.
1
Samples vary slightly from the 453 HIV-infected men due to missing values. Results are from separate models for each HIV-specific factor. Each regression models is adjusted for age, race, enrollment cohort, site, SBP, fasting glucose, total and HDL cholesterol, smoking, medication use, and body mass index (BMI).